Skip to main content
. 2024 Jun 26;150(16):1223–1235. doi: 10.1161/CIRCULATIONAHA.124.069907

Table 3.

Comparison of Primary and Secondary Outcomes Between High-Risk Subjects With and Without Using Aspirin in Intervention Phase

graphic file with name cir-150-1223-g007.jpg